Clinical impact of DPYD genotyping and dose adjustment in candidates for fluoropyrimidine treatment

Authors

Institutions

Publication Details

Journal
Heliyon
Published
2024-12-01
DOI
https://doi.org/10.1016/j.heliyon.2024.e40808
Citations
1
Primary Topic
Colorectal Cancer Treatments and Studies
Type
article
Field-Weighted Citation Impact
0.28

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical impact of DPYD genotyping and dose adjustment in candidates for fluoropyrimidine treatment

Andrés Corno-Caparrós, Ana Hernández-Guío, Fernando Gutiérrez-Nicolás, Miguel Ángel Calleja‐Hernández et al.
1 citations
Heliyon
Colorectal Cancer Treatments and Studies
0.28
article

Clinical impact of DPYD genotyping and dose adjustment in candidates for fluoropyrimidine treatment

Andrés Corno-Caparrós, Ana Hernández-Guío, Fernando Gutiérrez-Nicolás, Miguel Ángel Calleja‐Hernández, Marta Zayas-Soriano, Mari A. Bernabeu-Martínez
article en
1 citations

Abstract

No abstract available for this paper.
HeliyonVol. 10(23)
Universitat de Miguel Hernández d'Elx (ES), Hospital Universitario Virgen Macarena (ES), Hospital Universitari Sant Joan D'Alacant (ES), Gobierno de Canarias (ES)
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Good health and well-being
Openalex Percentile: Top 34%
Colorectal Cancer Treatments and Studies
0.28
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.